SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)
AUGUST 2, 2000 (AUGUST 2, 2000)
OMNI NUTRACEUTICALS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
UTAH 0-18160 87-046822
(STATE OF OTHER JURISDICTION (COMMISSION (IRS EMPLOYER
OF INCORPORATION) FILE NUMBER) IDENTIFICATION NO.)
5310 BEETHOVEN STREET
LOS ANGELES, CA 90066
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (310) 306-3636
N/A
(FORMER NAME AND FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
<PAGE>
OMNI NUTRACEUTICALS, INC.
TABLE OF CONTENTS
FOR
CURRENT REPORT ON FORM 8-K
Page No.
--------
Item 5. Other Events 3
Item 7. Exhibits 4
Signature 5
<PAGE>
ITEM 5
OTHER EVENTS
On July 25, 2000, Registrant announced the engagement of Rabobank to perform a
variety of investment banking services to explore strategic alternatives for the
Company, including possible debt or equity financings, recapitalization,
reorganization, joint venture, merger, sale, purchase, strategic alliance, etc.
A copy of the press release is attached hereto as an Exhibit.
ITEM 7
EXHIBITS
10.28 Press Release
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
OMNI NUTRACEUTICALS, INC.
Date: July__, 2000 By: /s/Klee Irwin
----------------
Klee Irwin
President and Chief Executive Officer
